Ozempic hits booze sales, Moderna likes AI, and Biogen’s blockbuster drug: Pharma news roundup

A new report from Morgan Stanley finds that people using GLP-1 drugs — among them Ozempic, Wegovy, Mounjaro, and Zepbound — reduce their consumption of tobacco and alcohol while taking the medications. Moderna and ChatGPT-maker OpenAI announced an ongoing partnership Wednesday to embed AI across Moderna’s business.…
Read more…

{Categories} _Category: Takes,*ALL*{/Categories}
{URL}https://qz.com/ozempic-wegovy-weight-loss-drug-prices-moderna-biogen-1851436487{/URL}
{Author}Bruce Gil{/Author}
{Image}https://i.kinja-img.com/image/upload/c_fill,h_675,pg_1,q_80,w_1200/3ac44423e35ce8fc395385f4901ca27f.jpg{/Image}
{Keywords}biogen,biogen,moderna,openai,novartis,merck,wegovy,lars fruergaard jorgensen,bristol myers squibb,pharmaceutical industry,keytruda,novo nordisk,glp 1,keytruda merck,chatgpt,anti obesity medication,astrazeneca,business finance,sanofi,health medical pharma,openai,glp 1 receptor agonist,semaglutide,bernie sanders,lars fruergaard,bristol myers squibb{/Keywords}
{Source}All{/Source}
{Thumb}https://i.kinja-img.com/image/upload/c_fit,q_80,w_636/3ac44423e35ce8fc395385f4901ca27f.jpg{/Thumb}

Exit mobile version